BackTSH Biopharm Limited Overview

TSH Biopharm Limited Current Cash

TSH Biopharm Limited's current cash is $620M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$618.68M
↑ 13.69% YoYΔ $74.51M vs prior year quarter

Peer trimmed avg / median

Loading

TSH Biopharm Limited Current Cash History

Loading

TSH Biopharm Limited vs. peers: Current Cash Comparison

Loading

TSH Biopharm Limited Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

TSH Biopharm Limited (8432.TWO) FAQ

As of the most recent data (June 2026), 8432.TWO shows a current cash of $620M. That compares with $540M in the prior-year period — up 13.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 8432.TWO's current cash is now $620M (was $540M) — a 13.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether TSH Biopharm Limited is outperforming or lagging.

Tracking 8432.TWO's current cash over time shows whether TSH Biopharm Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $620M That compares with $540M in the prior-year period — up 13.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has TSH Biopharm Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $620M) with ownership activity and broader fundamentals.